Augmentation of Cisplatin Cytotoxicity using Cytokines on Cervical Carcinoma Cell Lines
- 1 December 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 11 (6) , 349-354
- https://doi.org/10.1089/cbr.1996.11.349
Abstract
We investigated whether the biological response modifiers like IFN-α, IFN-γ and TNF-α could enhance the cytotoxic action of cisplatin on cervical carcinoma cell lines in vitro. The sensitivity of three cell lines SiHa, ME 180 and C33A to these agents was tested using colorimetric MTT assay as well as tritiated thymidine uptake. All the three cell lines demonstrated range of sensitivity to cisplatin and cytokines. Interferons and TNF when used in combination with lower dose of cisplatin showed a significant enhancement of cytotoxic action of the drug in all the cell lines. Thus these data indicate that cytokines in concert with the drug may have a potential to improve the 'in vivo' therapy in these patients.Keywords
This publication has 12 references indexed in Scilit:
- A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatmentCancer Chemotherapy and Pharmacology, 1996
- Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell linesJournal of Clinical Endocrinology & Metabolism, 1995
- Effect of interferon ? and tumour necrosis factor ? on sensitivity to cisplatin in ovarian carcinoma cell linesCancer Immunology, Immunotherapy, 1994
- Rationale of Combining Radiation and Interferon for the Treatment of Cervical CancerOncology, 1992
- Production of interleukin-1 and tumor necrosis factor by bone marrow-derived macrophages: effect of cisplatin and lipopolysaccharideImmunology Letters, 1991
- Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatinImmunology Letters, 1991
- Antiproliferative Effects of Cytokines on Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1991
- Original article: Potentiation of cisplatin by alpha-Interferon in advanced non-small cell lung cancer (NSCLC): A phase II studyAnnals of Oncology, 1990
- Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cellsGynecologic Oncology, 1990
- Lymphokines and cytokines as cancer treatment.Immunotherapy realizedCancer, 1990